Furthermore, the percentage of patients who used antiplatelets and insulin was higher in diabetic patients with lower limb complications than in those without lower limb ulcers, and the percentage of patients who used ACE inhibitors and statins was higher in diabetic patients with lower limb complications than in healthy controls. The gene discussed is ACE; the disease is ulcer of lower limb.